Correspondence 0001493152-23-026066 from MIRA PHARMACEUTICALS, INC. (MIRA) (CIK 0001904286) (MIRA)

MIRA PHARMACEUTICALS, INC. (MIRA) (CIK 0001904286)
Date: July 31, 2023 · CIK: 0001904286 · Accession: 0001493152-23-026066

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-273024

Date

July 31, 2023

Author

Chief

Form

CORRESP

Company

MIRA PHARMACEUTICALS, INC. (MIRA) (CIK 0001904286)

Letter

MIRA PHARMACEUTICALS, Inc.

900 West Platt Street, Suite 200

Tampa, Florida 33606

July 31, 2023

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

F Street, N.E.

Washington, D.C. 20549

Attn: Sasha Parikh, Kevin Vaughn, Jimmy McNamara, and Jason Drory

Re: MIRA Pharmaceuticals, Inc.

Registration Statement on Form S-1

Filed June 29, 2023

File No. 333-273024

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant, MIRA Pharmaceuticals, Inc., hereby requests that the above-referenced Registration Statement on Form S-1 be declared effective at 4:30 p.m., Eastern Standard Time, on Wednesday, August 2, 2023, or as soon as practicable thereafter. The Registrant respectfully requests that you notify Neda Sharifi and Curt Creely of Foley & Lardner LLP of such effectiveness by a telephone call to (904) 359-8719 or (813) 225-4122.

Very
truly yours,
mira
pharmaceuticals, Inc.

Show Raw Text

CORRESP
1
filename1.htm

MIRA
PHARMACEUTICALS, Inc.

900 West Platt Street, Suite 200

Tampa, Florida 33606

July
31, 2023

VIA
EDGAR

U.S.
Securities and Exchange Commission

Division
of Corporation Finance

Office
of Life Sciences

100
F Street, N.E.

Washington,
D.C. 20549

Attn:
Sasha Parikh, Kevin Vaughn, Jimmy McNamara, and Jason Drory

    Re:
    MIRA
    Pharmaceuticals, Inc.

    Registration
    Statement on Form S-1

    Filed
    June 29, 2023

    File
    No. 333-273024

Ladies
and Gentlemen:

Pursuant
to Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant, MIRA Pharmaceuticals, Inc., hereby requests that
the above-referenced Registration Statement on Form S-1 be declared effective at 4:30 p.m., Eastern Standard Time, on Wednesday, August
2, 2023, or as soon as practicable thereafter. The Registrant respectfully requests that you notify Neda Sharifi and Curt Creely of Foley & Lardner LLP of such effectiveness by a telephone call to (904) 359-8719 or (813) 225-4122.

    Very
    truly yours,

    mira
    pharmaceuticals, Inc.

    By:

    /s/
    Erez Aminov

    Erez
    Aminov

    Chief
    Executive Officer

SecProbe.io